Monoclonal antibodies to legionella, a process for their preparation and their use in the determination of legionella pneumophila
US4780407A · kind A · utility
9Cited by
1References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 1, 1987 |
| Grant date | Oct 25, 1988 |
| Priority date | — |
| Expiry date | Jul 1, 2007 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/975
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
A process to produce hybrid cell lines, which produce monoclonal antibodies to Legionella pneumophila. Cell lines are produced by fusion of immunized mouse splenocytes to these bacteria with non secreting myeloma cells. Monoclonal antibodies are useful for diagnosis of diseases due to Legionella pneumophilia, for detection of these bacteria in environment, for the production of vaccines.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.